Skip to main content

Bonita David P

In the past year, 1 open-market purchase filing worth $12.5M and no sales.

Current role at each company

Show 2 more companies

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$12.5M
1 filing
Sold
–
0 filings
Net
+$12.5M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Bonita David P as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

PRLD Prelude Therapeutics Inc

Director, 10% Owner2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 23, 2026 (view filing)Apr 212 daysBonita David PDirector, 10% OwnerPPurchase+2.82M$4.44+$12.5MNew position1.13M after2 lots
May 24, 2023 (view filing)May 222 daysBonita David PDirector, 10% OwnerPPurchase+869.6K$5.75+$5.00M+9.4%10.1M after

IMA ImageneBio, Inc.

Director3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 16, 2026 (view filing)Apr 142 daysBonita David PDirectorPPurchase+721.3K–––384.7K afterDerivative2 lots
Jul 30, 2025 (view filing)Jul 255 daysLateBonita David PDirectorPPurchase+83.6K$29.90+$2.50M+40.9%287.9K after
Jun 24, 2022 (view filing)Jun 22-242 daysBonita David PDirectorPPurchase−252.2K$4.47−$1.13M−10.7%2.10M after4 lots

TCDA Tricida, Inc.

Director, 10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 25, 2022 (view filing)8:08 PM ETNov 22-253 daysBonita David PDirector, 10% OwnerSSale−10.3M$0.2145−$2.21M−100.0%0 after3 lots

THRD Third Harmonic Bio, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 21, 2022 (view filing)Sep 192 daysBonita David PDirector, 10% OwnerPPurchase+300.0K$17.00+$5.10M+5.5%5.78M after

RPTX Repare Therapeutics Inc.

Director6 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 8, 2021 (view filing)Sep 3-75 daysBonita David PDirectorSSale−8.08K$33.99−$274.8K−7.8%96.2K after4 lots
Sep 2, 2021 (view filing)Aug 31-Sep 22 daysBonita David PDirectorSSale−37.9K$34.08−$1.29M−28.2%96.4K after6 lots
Aug 30, 2021 (view filing)Aug 26-304 daysBonita David PDirectorSSale−18.1K$34.07−$615.7K−15.6%97.5K after6 lots
Aug 25, 2021 (view filing)Aug 23-252 daysBonita David PDirectorSSale−18.2K$34.17−$622.4K−15.7%98.1K after6 lots
Aug 25, 2021 (view filing)Aug 17-188 daysLateBonita David PDirectorSSale−20.3K$34.10−$693.2K−17.1%98.6K after4 lotsDuplicate filing
Aug 19, 2021 (view filing)Aug 17-182 daysBonita David PDirectorSSale−20.3K$34.10−$693.2K−17.1%98.6K after4 lots

ELVN Enliven Therapeutics, Inc.

Director, 10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 23, 2021 (view filing)Jul 167 daysBonita David PDirector, 10% OwnerPPurchase+1.67M$6.00+$10.0M+65.8%4.20M afterAmended

AFIB Acutus Medical, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 21, 2021 (view filing)Jul 192 daysBonita David PDirector, 10% OwnerPPurchase+1.07M$14.00+$15.0M+176.8%1.68M after2 lots